Monograph Details
|
|
Cardiovascular System
> Hypertension
|
|
MICARDIS |
| Manufacturer |
|
Boehringer Ingelheim Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Angiotensin II receptor blocker. |
| Generic Name |
|
Telmisartan 20mg, 40mg, 80mg; tabs. |
| Indications |
|
Hypertension. |
| Children |
|
Not recommended. |
| Adults |
|
Not volume-depleted: initially 40mg once daily; usual range 20–80mg/day. Salt/volume depleted: monitor closely or consider alternative therapy. May add diuretic if insufficient response at 80mg/day. |
| Contraindications |
|
Pregnancy (Cat.D in 2nd and 3rd trimesters). |
| Precautions |
|
Correct hypovolemia before starting therapy or monitor closely. Hepatic insufficiency. Biliary obstruction. Severe renal impairment or CHF. Renal artery stenosis. Dialysis (monitor for orthostatic hypotension). Pregnancy (Cat.C in 1st trimester). Nursing mothers: not recommended. |
| Interactions |
|
Hyperkalemia with K+ supplements, K+ sparing diuretics, K+ containing salt substitutes. May potentiate digoxin. |
| Adverse Reactions |
|
Back pain, upper respiratory tract infection, sinusitis, diarrhea, pharyngitis, angioedema, rhabdomyolysis (rare). |
| How Supplied |
|
Tabs—28 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
